Omar F. Khan Institute of Biomaterials and Biomedical Engineering / Department of Chemical Engineering and Applied Chemistry University of Toronto Biography Publications Institution JoVE Articles Omar F. Khan has not added a biography. If you are Omar F. Khan and would like to personalize this page please email our Author Liaison for assistance. Publications Toward an In Vitro Vasculature: Differentiation of Mesenchymal Stromal Cells Within an Endothelial Cell-Seeded Modular Construct in a Microfluidic Flow Chamber Tissue Engineering. Part A. Dec, 2011 | Pubmed ID: 21992078 Endothelialized Biomaterials for Tissue Engineering Applications in Vivo Trends in Biotechnology. Aug, 2011 | Pubmed ID: 21549438 In-vitro Antiproliferative Activity of Benzopyranone Derivatives in Comparison with Standard Chemotherapeutic Drugs Archiv Der Pharmazie. Feb, 2011 | Pubmed ID: 21290426 Endothelial Cell Behaviour Within a Microfluidic Mimic of the Flow Channels of a Modular Tissue Engineered Construct Biomedical Microdevices. Feb, 2011 | Pubmed ID: 20842530 Patterning Collagen/Poloxamine-Methacrylate Hydrogels for Tissue-Engineering-Inspired Microfluidic and Laser Lithography Applications Journal of Biomaterials Science. Polymer Edition. Dec, 2010 | Pubmed ID: 21144168 In-vitro Antiproliferative Activity of Benzopyranone Derivatives in Comparison with Standard Chemotherapeutic Drugs Archiv Der Pharmazie. Nov, 2010 | Pubmed ID: 21117082 Perfusion and Characterization of an Endothelial Cell-seeded Modular Tissue Engineered Construct Formed in a Microfluidic Remodeling Chamber Biomaterials. Nov, 2010 | Pubmed ID: 20678792 Synthesis and Antimicrobial Activity of N,N'-Bis(2-hydroxylbenzyl)-1,2-ethanediamine Derivatives Letters in Drug Design & Discovery. Mar, 2010 | Pubmed ID: 20548968 MMP Levels in the Response to Degradable Implants in the Presence of a Hydroxamate-based Matrix Metalloproteinase Sequestering Biomaterial in Vivo Journal of Biomedical Materials Research. Part A. Jun, 2010 | Pubmed ID: 19911383 Synthesis and Antiproliferative Activity of Coumarin-estrogen Conjugates Against Breast Cancer Cell Lines Letters in Drug Design & Discovery. Mar, 2009 | Pubmed ID: 20556210 Synthesis and Pharmacology of Anti-inflammatory Steroidal Antedrugs Chemical Reviews. Dec, 2008 | Pubmed ID: 19035773 A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer Current Medicinal Chemistry. 2008 | Pubmed ID: 18991629 Trypanothione Reductase: a Viable Chemotherapeutic Target for Antitrypanosomal and Antileishmanial Drug Design Drug Target Insights. 2007 | Pubmed ID: 21901070 Medicinal Chemistry and Emerging Strategies Applied to the Development of Selective Estrogen Receptor Modulators (SERMs) Current Medicinal Chemistry. 2007 | Pubmed ID: 17504144 In Vitro Anti-inflammatory Activities of New Steroidal Antedrugs: [16alpha,17alpha-d] Isoxazoline and [16alpha,17alpha-d]-3'-hydroxy-iminoformyl Isoxazoline Derivatives of Prednisolone and 9alpha-fluoroprednisolone Steroids. Mar, 2006 | Pubmed ID: 16309722 Antedrugs: an Approach to Safer Drugs Current Medicinal Chemistry. 2005 | Pubmed ID: 16178782 Fabricatie van Micro-weefsels met behulp van modules van Collageen gel met cellen M. Dean Chamberlain1, Mark J. Butler1, Ema C. Ciucurel1, Lindsay E. Fitzpatrick2, Omar F. Khan1, Brendan M. Leung2, Chuen Lo1, Ritesh Patel2, Alexandra Velchinskaya2, Derek N. Voice2, Michael V. Sefton1 1Institute of Biomaterials and Biomedical Engineering / Department of Chemical Engineering and Applied Chemistry, University of Toronto, 2Institute of Biomaterials and Biomedical Engineering, University of Toronto JoVE 2177 Bioengineering
Fabricatie van Micro-weefsels met behulp van modules van Collageen gel met cellen M. Dean Chamberlain1, Mark J. Butler1, Ema C. Ciucurel1, Lindsay E. Fitzpatrick2, Omar F. Khan1, Brendan M. Leung2, Chuen Lo1, Ritesh Patel2, Alexandra Velchinskaya2, Derek N. Voice2, Michael V. Sefton1 1Institute of Biomaterials and Biomedical Engineering / Department of Chemical Engineering and Applied Chemistry, University of Toronto, 2Institute of Biomaterials and Biomedical Engineering, University of Toronto JoVE 2177 Bioengineering
